Bill > HR5462

This bill aims to modify the definition of an "institution for mental diseases" (IMD) under the Medicaid program by excluding facilities with 36 beds or fewer from the current definition, provided they meet specific national standards. Specifically, these smaller institutions would be exempt from the IMD classification if they adhere to evidence-based standards approved by the Secretary of Health and Human Services, which include requirements for types of services offered, clinical care hours, and staff credentials. For substance use disorder treatment facilities, this means additionally meeting standards set by the American Society of Addiction Medicine. The bill, named the Michelle Alyssa Go Act, would take effect 180 days after enactment and apply to state Medicaid plans from that date forward. The significance of this change is that smaller mental health and substance use disorder treatment facilities would have more flexibility in their classification and potentially in their Medicaid reimbursement and regulatory requirements.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/5462/all-info